Citations 1
Targeting HSP90 in breast cancer: Enchant-1 (NCT01677455) phase 2 proof of concept study of ganetespib in first-line treatment of women with metastatic breast cancer.
Spector, Neil L., Mano, Max S. , Canon, Jean-Luc, Gómez, Henry , El‐Hariry, Iman , Vukovic, Vojislav, Sheldon, Emily H, Perez, Edith A. , Cameron, David , Cortés, Javier , Canon, Jean-Luc Re , Hickish, Tamas , Vahdat, Linda T. , Kim, Sung-Bae , Awada, Ahmad
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS665-TPS665
